STAT3 and cardiac hypertrophy: The graphical summary depicts the established signaling and metabolic pathways that were significantly altered (Fig. S3), most notably upregulation of cardiac hypertrophy and the STAT3 pathway as well as downregulation of synaptogenesis signaling and synaptic long-term depression (Fig. 2c).